PersonScientistFounder
Jean Cui
J. Jean Cui is a medicinal chemist who has invented three FDA-approved cancer medicines and now runs the biotech she founded to do it again. As scientific founder, President and CEO of BlossomHill Therapeutics in San Diego, she designs small molecules built to outmaneuver the resistance mutations that defeat earlier drugs. Her crizotinib, lorlatinib and repotrectinib all began as chemistry problems she solved at the molecular level. In 2024 she was elected to the National Academy of Engineering. Her track record includes co-founding Turning Point Therapeutics, which Bristol Myers Squibb bought for $4.1 billion.
jean cuij. jean cuijingrong jean cuiblossomhill therapeuticsturning point therapeuticsdrug discovery
